This webpage contains legacy information. The product is either no longer available from the supplier or has been delisted at Labome.
product summary
company name :
Bio-Rad
other brands :
Biogenesis, Serotec, AbD Serotec, Oxford Biotechnology
product type :
antibody
product name :
GOAT ANTI HUMAN FURIN (C-TERMINAL)
catalog :
AHP2262
quantity :
0.1 mg
price :
439 USD
clonality :
polyclonal
host :
domestic goat
conjugate :
nonconjugated
reactivity :
human
application :
western blot, ELISA
product information
Entity Type :
Polyclonal Antibody
Entity Category :
Antibodies
Region :
(C-TERMINAL)
ProductCode :
AHP2262
Description :
GOAT ANTI HUMAN FURIN (C-TERMINAL)
Specificity :
FURIN
TargetSpecies :
Human
Host :
Goat
Format :
Purified
Isotypes :
Polyclonal IgG
Applications :
E,WB
ApplicationTypes :
Western Blotting,ELISA
Cross Reactivities :
Bovine,Dog,Mouse,Pig,Rat
Quantity :
0.1 mg
Quantity Value :
0.1
Quantity Type :
mg
GO Accessions :
GO:0051044,GO:0048011,GO:0045121,GO:0043687,GO:0043043,GO:0042277,GO:0032940,GO:0032911,GO:0032902,GO:0032804,GO:0002020,GO:0000139,GO:0005886,GO:0048406,GO:0004867,GO:0016021,GO:0004252,GO:0032455,GO:0030140,GO:0019067,GO:0017187,GO:0009986,GO:0008283,GO:0007219,GO:0007179,GO:0006465,GO:0005802,GO:0005796,GO:0046872
GOTerms :
bacterial inner membrane,cell membrane,cytoplasmic membrane,GO:0005904,inner endospore membrane,juxtamembrane,plasma membrane lipid bilayer,plasmalemma,blood coagulation factor activity,transmembrane,serine protease inhibitor activity,serine proteinase inhibitor activity,serpin activity,neurotrophin TRKA receptor activity,NGF binding,heavy metal binding,metal binding,Golgi trans face,Golgi trans-face,late Golgi,maturing face,TGN,trans Golgi network,leader peptide processing,TGFbeta receptor signaling pathway,TGF-beta receptor signaling pathway,TGFbeta receptor signalling pathway,TGF-beta receptor signalling pathway,transforming growth factor beta receptor signalling pathway,GO:0030179,N signaling pathway,N signalling pathway,Notch receptor signaling pathway,Notch receptor signalling pathway,Notch signalling pathway,Notch-receptor signaling pathway,Notch-receptor signalling pathway,cell associated,cell bound,GO:0009928,GO:0009929,TGN transport vesicle,down regulation of low-density lipoprotein receptor catabolic process,down-regulation of low-density lipoprotein receptor catabolic process,downregulation of low-density lipoprotein receptor catabolic process,inhibition of low-density lipoprotein receptor catabolic process,negative regulation of low-density lipoprotein receptor breakdown,negative regulation of low-density lipoprotein receptor catabolic process,negative regulation of low-density lipoprotein receptor catabolism,negative regulation of low-density lipoprotein receptor degradation,NGF production,down regulation of transforming growth factor-beta1 production,down-regulation of transforming growth factor-beta1 production,downregulation of transforming growth factor-beta1 production,inhibition of transforming growth factor-beta1 production,negative regulation of TGFB1 production,negative regulation of TGF-B1 production,cellular secretion,peptide anabolism,peptide biosynthesis,peptide formation,peptide synthesis,posttranslational amino acid modification,post-translational amino acid modification,posttranslational modification,post-translational modification,posttranslational protein modification,PTM,GEM domain,glycolipid-enriched membrane domain,lipid raft,nerve growth factor receptor signalling pathway,NGF receptor signaling pathway,NGF receptor signalling pathway,activation of membrane protein ectodomain proteolysis,stimulation of membrane protein ectodomain proteolysis,up regulation of membrane protein ectodomain proteolysis,upregulation of membrane protein ectodomain proteolysis,up-regulation of membrane protein ectodomain proteolysis
Uniprot Accessions :
P09958
Gene :
FURIN
GeneID URL :
http://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=5045
Published Synonyms :
PACE
Entity Formats :
Purified
UNSPSC :
41116161
Concentration :
IgG concentration 0.5mg/ml
Product Form :
Purified IgG - liquid
PriceGBP :
313
PriceEUR :
439
PriceUSD :
439 USD
PriceCHF :
478
PriceSEK :
4785
PriceNOK :
4809
PriceDKK :
3273
NotForSaleInCountries :
New Zealand,Canada
company information

Bio-Rad
Endeavour House, Langford Business Park
Langford Lane, Kidlington
OXON, OX5 1GE
Langford Lane, Kidlington
OXON, OX5 1GE
antibody_sales_uk@bio-rad.com
https://www.bio-rad-antibodies.com1 800 265 7376 (North America)
44 (0)1865 852 700 (Rest of World)
44 (0)1865 852 700 (Rest of World)
headquarters: UK
Bio-Rad is one of the world's leading antibody manufacturers, offering over 12,000 antibodies and related reagents for a focused range of research areas such as immunology, cancer, veterinary research and cell biology through its antibody experts formerly known as AbD Serotec.
The range includes apoptosis kits, autophagy reagents, CD markers, epitope tag antibodies, immunology antibodies, neuroscience antibodies, and veterinary reagents.
Bio-Rad has an ISO 9001 and ISO 13485 certified production facility in the United Kingdom as well as ISO 9001 certified facilities in Germany and the United States.
Our expertise extends to traditional and recombinant antibody generation and production services. Our custom generation service delivers antibodies in as little as 8 weeks with greater than 90% success. The in vitro technology enables selection of antibodies to challenging targets, long term consistent supply, and provision of the antibody sequence.
At Bio-Rad we are committed to your success when using our antibodies and we focus on providing the technology, products and all the supporting information you need to excel in your research.
The range includes apoptosis kits, autophagy reagents, CD markers, epitope tag antibodies, immunology antibodies, neuroscience antibodies, and veterinary reagents.
Bio-Rad has an ISO 9001 and ISO 13485 certified production facility in the United Kingdom as well as ISO 9001 certified facilities in Germany and the United States.
Our expertise extends to traditional and recombinant antibody generation and production services. Our custom generation service delivers antibodies in as little as 8 weeks with greater than 90% success. The in vitro technology enables selection of antibodies to challenging targets, long term consistent supply, and provision of the antibody sequence.
At Bio-Rad we are committed to your success when using our antibodies and we focus on providing the technology, products and all the supporting information you need to excel in your research.
questions and comments